a public good project by the
Synthesis
Company
of California

© 2026

Helen Kiriazis | doi.page

0 works0 citations0 h-index

Helen Kiriazis

Baker Heart and Diabetes Institute(AU)The University of Melbourne(AU)Melbourne Health(AU)

Publications by Year

Research Areas

Cardiovascular Function and Risk Factors, Cardiac Fibrosis and Remodeling, Cardiomyopathy and Myosin Studies, Adipose Tissue and Metabolism, Cardiac electrophysiology and arrhythmias

Most-Cited Works

→ Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function(2012)428 cited
→ Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease(2020)386 cited
→ Relaxin Reverses Cardiac and Renal Fibrosis in Spontaneously Hypertensive Rats(2005)197 cited
→ Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation(2009)185 cited
→ Compensatory Growth of Healthy Cardiac Cells in the Presence of Diseased Cells Restores Tissue Homeostasis during Heart Development(2008)177 cited
→ PI3K(p110α) Protects Against Myocardial Infarction-Induced Heart Failure(2010)171 cited

→ Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes(2012)162 cited

→ Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis(2006)157 cited

→ Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy(2010)145 cited

→ Phosphoinositide 3-Kinase p110α Is a Master Regulator of Exercise-Induced Cardioprotection and PI3K Gene Therapy Rescues Cardiac Dysfunction(2012)144 cited